Alkaline Phosphatase(ALP) Examination Procedure
1.Purpose of examination:
Alkaline Phosphatase estimation from serum or plasma by Para-nitrophenyl Phosphate Method.
2.Responsibility and Authority:
Calibration: Technician
Quality Control: Technician
Routine operation: Technician
Overall Monitoring: Quality Manager
3.Sample Details:
Type of Sample: Serum, Plasma
Type of container and additives: Plain without any additives
-
Stability: At Room temperature 18°–28°C (64°–82°F) stability ≤ 24 hours
Handling and transport: As per Primary Sample collection manual
Storage: 24 hours at 2-8° C
4.Required Equipment:
Centrifuge, Auto-Pipette, Disposable Tips, Disposable sample cups, FullyAuto Chemistry Analyzer
5.Required reagents:
6.Reagent Handling
Remove any air bubbles present in the reagents with a new applicator stick, or allow the reagents to settle at the appropriate storage temperature to allow the bubbles to dissipate. To minimize volume depletion, do not use a transfer pipette to remove bubbles
Reagent Storage and stability
Unopened reagent stable at 2-8°C until expiration date.
On board System temperature reagent is stable for 10 days
Instability or deterioration should be suspected if there are precipitates, visible signs of leakage or
contamination, turbidity, or if calibration or controls do not meet the appropriate criteria.
7.Calibration Procedure:
Consolidated Chemistry Calibrators(CONCC) - Level 1 & 2
Frequency:
Reagent lot change
QC out of range
After service or maintenance
Replacement in any parts of Instrument
Procedure:
Start the equipment.WDI abbotte fully.docx
Calibrators are ready to use.
Put calibrator 15-20 minutes at room temperature
Prior to use, mix the contents by inverting the vial. Do not shake the vial to prevent foam formation.
Take a 150 µl both level of calibrator solution in to separate aliquot.
Go to the calibration and give the calibration order.
Verify calibration with at least two levels of controls
If control results fall outside acceptable ranges,root cause analysis or recalibration may be necessary.
8.Quality control Procedure:
Name: Biorad Level 1 & 2
Frequency: As per Quality Control Procedure
9.Procedure for Reconstitution of IQC
Reconstitution of QC material with 5 ml Distilled water by using calibrated fixed volume pipette.
Leave to stand for 30 min in the dark place.
Swirl gently several times during the reconstitution period to ensure that the contents are completely dissolved.
Prior to use, mix the contents by inverting the vial. Do not shake the vial as the information of foam should be avoided. Ensure that no lyophilized material remains un-reconstituted.
Prepare aliquots of 150 µl from the reconstituted QC material.
Store these aliquots at -15° C to -20° C.
Prior to use, make sure that aliquots should be at room temperature for at least 15 min.
Procedure to run IQC
Press Control order
Select Assay /Panel, to be run.
Select the control/s and its level/s
Give Carrier Number and Position number
Press F3 / Add order
Put respected carrier in RSH rack
Check IQC results, in case outliers call residents.
10.Principle of the procedure used for examinations:
ALP in sample catalyzes the hydrolysis of colorless Para Nitrophenyl Phosphate to give paranitrophenol and inorganic phosphate. In alkaline pH paranitrophenol is in the yellow phenoxide form.The rate of absorbance increase at 404 nm is a directly proportional to ALP activity in sample.
11.Sample Preparation:
12.Procedure to run Patient sample
Press Patient order
Select Assay /Panel, to be run.
Give Carrier Number and Position number
Press F3 / Add order
Put respected carrier in RSH rack
13.Performance Characteristics:
If values exceed this linearity limit 4500 U/L, dilute the sample by Manual Dilution Procedure, or the Automatic Dilution Protocol provided in the assay parameters.
Automated Dilution Protocol:
When using the Automated Dilution Protocol, the system performs a dilution of the specimen and automatically corrects the concentration by multiplying the result by the appropriate dilution factor.
Manual Dilution Procedure:
Dilute the specimen with saline (0.85% to 0.90% NaCl). Enter the dilution factor in the Patient or Control order screen
Normal and critical ranges:
0-15 y | 54-369 | U/L |
16-50 y | 53-128 | U/L |
>50 y | Male | 56-119 | U/L |
>50 y | Female | 53-141 | U/L |
14.Laboratory Clinical interpretation:
A rise in ALP activity occurs with all forms of cholestasis, particularly with obstructive jaundice. ALP is also elevated in disorders of the skeletal system that involve osteoblast hyperactivity and bone remodeling, such as Paget disease, rickets, osteomalacia, fractures, and malignant tumors. Moderate elevation of ALP may be seen in other disorders such as Hodgkin disease, congestive heart failure, ulcerative colitis, regional enteritis, and intra-abdominal bacterial infections.
15.Interference and cross reaction:
No interference from Conjugated Bilirubin 15 up to U/L
No interference from Unconjugated Bilirubin 20 up to U/L
No interference from Hemoglobin up to 250 U/L
No interference from Intralipid up to1500 U/L
16.Potential source of variation:
Turn around time (TAT):
Routine: 6.0 hours
Urgent: 2.0 hours
17.Recording of observation:
Software backup
Machine raw data
18.Storage & Disposal of waste: Follow storage & discard procedure
19.Environmental & Safety control:
20.Precautions:
Wear protective gloves / protective clothing / eye protection
Do not breathe mist / vapors / spray
Wash hands thoroughly after handling
Keep only in original container
21.Response
IF SWALLOWED: Rinse mouth. Do NOT induce vomiting
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing
IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water / shower.
Reagent R2 contains methylisothiazolones that Causes severe skin burns and eye Damage .
22.References:
US department of labor,Occupational safety and health administration.
US department of health and human services. Biosafety in MIcrobiological and biomedical laboratories.
World health organization. Biosafety manual,3rd edition
ARCHITECT ALP 7D55 307217/R01
NABL 112 effective from 01/06/2019
Printed copy of this document is considered uncontrolled. It should be compared with controlled electronic copy before use |
Name of Laboratory : Laboratory Services Sir T. Hospital (LSSTH),Bhavnagar |
Document No.1 | Document Name: Alkaline Phosphatase(ALP) Examination Procedure | Unique ID:LSSTH /BIOCHEM/ SOP-5 |
Issue No. : 01 | Issue Date :30/04/2024 | Page No. |
Amend No. | Amend Date | Prepared by: Section Incharge | Approved & Issued by: HOD,Biochemistry |